FindMyRecallSubscribe
Class I: serious health riskTerminated

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon Advil Liqui Gels Recall

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (N…

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon · Warren, NJ

Risk level
Class I
Reported by FDA
Feb 1, 2023
Recall ID
D-0182-2023
Check your lot numberHow we source this data

Summary

Glaxosmithkline Consumer Healthcare Holdings DBA Haleon recalled Advil Liqui Gels starting Dec 6, 2022. The FDA classified it as Class I (serious health risk) and published enforcement report D-0182-2023 on Feb 1, 2023. Reason: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back. Status: Terminated.

Why it was recalled

Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back

Product description

Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3

Lot numbers, UPCs & expiration codes

Lot: R94065, Exp 02/29/2024

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0182-2023
Classification
Class I
Status
Terminated
Recall initiated
Dec 6, 2022
FDA report date
Feb 1, 2023
Quantity
88,380 capsules
Recall type
Voluntary: Firm initiated
Recalling firm
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon

Original FDA data

Every field from FDA enforcement report D-0182-2023, exactly as published.

Show all FDA fields
City
Warren
State
NJ
Status
Terminated
Country
United States
Event ID
91259
Address
184 Liberty Corner Rd
Code information
Lot: R94065, Exp 02/29/2024
Postal code
07059-6796
Report date
Feb 1, 2023
Product type
Drugs
Recall number
D-0182-2023
Classification
Class I
Recalling firm
Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
Product quantity
88,380 capsules
Termination date
Feb 26, 2024
Reason for recall
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Voluntary / mandated
Voluntary: Firm initiated
Product description
Advil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Distributed by: Pfizer, Madison, NJ 07940, UPC 3 0573 0169 49 3
Distribution pattern
Nationwide in the USA.
Recall initiation date
Dec 6, 2022
Initial firm notification
Letter
Center classification date
Jan 25, 2023

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0182-2023, published Feb 1, 2023. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls